Moreover, previous studies in breast cancer and Burkitt's lymphoma suggest that methylation in cyclin D2 is a tumour-specific event (Sinclair et al, 1995; Evron et al, 2001; Lehmann et al, 2002). This evidence concerns the gene CCND2 and breast cancer.